Name | Value |
---|---|
Revenues | 84.2M |
Cost of Revenue | 38.1M |
Gross Profit | 46.1M |
Operating Expense | 42.8M |
Operating I/L | 6.6M |
Other Income/Expense | 15.1M |
Interest Income | 0.0M |
Pretax | 8.9M |
Income Tax Expense | 2.3M |
Net Income/Loss | 6.6M |
Procaps Group, S.A. is an integrated healthcare and pharmaceutical company that formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. The company also provides over-the-counter (OTC) consumer healthcare products in approximately ten therapeutic areas, such as gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements. Additionally, it offers blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions. Procaps Group also specializes in contract drug development and manufacturing services, particularly soft gelatin capsule technologies.